Search company, investor...

Leptos BioMedical

Founded Year



Series C | Alive

Total Raised


Last Raised

$20M | 15 yrs ago

About Leptos BioMedical

Leptos Biomedical is developing an impressive new electrical stimulation device treating obesity.

Headquarters Location

452 Northco Drive Suite 100

Fridley, Minnesota, 55432,

United States


Missing: Leptos BioMedical's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Leptos BioMedical's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Leptos BioMedical Patents

Leptos BioMedical has filed 5 patents.

patents chart

Application Date

Grant Date


Related Topics




Diabetes, Obesity, Syndromes, Nutrition, Rare diseases


Application Date


Grant Date



Related Topics

Diabetes, Obesity, Syndromes, Nutrition, Rare diseases



Leptos BioMedical Frequently Asked Questions (FAQ)

  • When was Leptos BioMedical founded?

    Leptos BioMedical was founded in 2002.

  • Where is Leptos BioMedical's headquarters?

    Leptos BioMedical's headquarters is located at 452 Northco Drive, Fridley.

  • What is Leptos BioMedical's latest funding round?

    Leptos BioMedical's latest funding round is Series C.

  • How much did Leptos BioMedical raise?

    Leptos BioMedical raised a total of $20M.

  • Who are the investors of Leptos BioMedical?

    Investors of Leptos BioMedical include Technology Partners, Latterell Venture Partners, Spray Venture Partners and Thomas McNerney & Partners.

  • Who are Leptos BioMedical's competitors?

    Competitors of Leptos BioMedical include Epitomee Medical, Bioness, OptiScan Biomedical, Celonova Biosciences, Synapse Biomedical, Rheonix, Salutaris Medical Devices, Neuronetics, BAROnova, Transcend Medical and 17 more.

Compare Leptos BioMedical to Competitors

E-Pill Pharma

E-Pill Pharma - Develops an "electrical pill" performing electrical nerve stimulation of the intestines (ENSI). ENSI affects the absorption properties of the GI tract membrane.


CoRepair, Inc. is developing a radiofrequency (RF) device system for the treatment of congestive heart failure.


MetaCure is a clinical-stage device company focused on the treatment of adult type II diabetes via an implantable pulse generator delivering electrical stimulation via gastric contractility modulation.

Cerapedics Logo

Cerapedics is a privately held medical device company focused on developing and commercializing osteobiologic products based on its anorganic bone mineral (ABM) and synthetic small peptide (P-15) technology platform for use in a wide variety of spine, trauma and orthopedic surgical procedures. i-FACTOR bone graft is a biologic bone graft that utilizes a synthetic small peptide as an attachment factor intended to stimulate the natural bone healing process resulting in safe, predictable bone formation at a fraction of the cost of growth factors.


Cardiola have designed a patented device, the m.pulse device designed to treat chronic heart failure (CHF), non-surgically, in a patient's home.

Moximed Logo

Moximed is a developer of unicompartmental load absorber implants for active patients with painful knee osteoarthritis (OA). The Moximed implants do not require bone cutting or bone removal, and, importantly, they absorb excess joint load rather than shift load to other areas of the joint. The company is based in Fremont, California.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.